Agile Therapeutics, Inc.’s (AGRX) CEO Al Altomari on Q2 2021 Results – Earnings Call Transcript

Agile Therapeutics, Inc. (NASDAQ:AGRX) Q2 2021 Earnings Conference Call July 26, 2021 4:30 PM ET
Company Participants
Matt Riley – Head, Investors Relations
Al Altomari – Chairman and CEO
Dennis Reilly – Chief Financial Officer
Conference Call Participants

Click here to view the original article.